Organogenesis Holdings Inc (ORGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 150,864 | 101,005 | 86,693 | 126,656 | 115,177 |
| Cost of Goods | 36,251 | 27,630 | 23,723 | 31,051 | 26,796 |
| Gross Profit | 114,613 | 73,375 | 62,970 | 95,605 | 88,381 |
| Operating Expenses | 94,137 | 86,581 | 90,439 | 85,437 | 82,935 |
| Operating Income | 20,727 | -12,576 | -26,746 | 10,219 | 6,242 |
| Other Income | 433 | 742 | 963 | 34 | -419 |
| Pre-tax Income | 21,160 | -11,834 | -25,783 | 10,253 | 5,823 |
| Income Tax | -407 | -2,442 | -6,940 | 2,580 | -6,508 |
| Net Income Continuous | 21,567 | -9,392 | -18,843 | 7,673 | 12,331 |
| Net Income | $21,567 | $-9,392 | $-18,843 | $7,673 | $12,331 |
| EPS Basic Total Ops | 0.11 | -0.10 | -0.17 | 0.05 | 0.09 |
| EPS Basic Continuous Ops | 0.17 | -0.07 | -0.15 | 0.06 | 0.09 |
| EPS Diluted Total Ops | 0.11 | -0.10 | -0.17 | 0.05 | 0.09 |
| EPS Diluted Continuous Ops | 0.16 | -0.07 | -0.15 | 0.06 | 0.09 |
| EPS Diluted Before Non-Recurring Items | 0.18 | -0.09 | -0.13 | 0.04 | 0.09 |
| EBITDA(a) | $27,714 | $-5,921 | $-20,463 | $16,639 | $12,659 |